.Attribute Medicine, Published online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medication conjugate (ADC) tisotumab vedotin caused strengthened progression-free and overall survival, bring about FDA approval as well as a brand new procedure alternative for clients.